Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

This study is ongoing, but not recruiting participants.

Study NCT00041080 Information provided by National Cancer Institute (NCI)

First Received: July 8, 2002 Last Updated: June 6, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Fallopian Tube Cancer
Ovarian Cancer
Peritoneal Cavity Cancer

Additional conditions recognized in this trial

Fallopian Tube Neoplasms
Ovarian Neoplasms
Peritoneal Neoplasms

More general conditions related to this trial

Abdominal Neoplasms
Adnexal Diseases
Digestive System Diseases
Digestive System Neoplasms
Endocrine Gland Neoplasms
Endocrine System Diseases
Fallopian Tube Diseases
Genital Diseases, Female
Genital Neoplasms, Female
Gonadal Disorders
Neoplasms
Neoplasms by Site
Ovarian Diseases
Peritoneal Diseases
Urogenital Neoplasms

Interventions listed in this trial

tamoxifen citrate
thalidomide

Additional drug interventions recognized in this trial

Tamoxifen

Sponsors listed in this trial

Gynecologic Oncology Group
National Cancer Institute (NCI)

Back to top of Main Content